Close
  Indian J Med Microbiol
 

Figure 3 A comparison of histamine levels at the sixth month between chronic myeloid leukemia (CML) patients who achieved optimal, warning, and failure response to tyrosine kinase inhibitors (TKIs) (P = 0.007).

Figure 3 A comparison of histamine levels at the sixth month between chronic myeloid leukemia (CML) patients who achieved optimal, warning, and failure response to tyrosine kinase inhibitors (TKIs) (<i>P</i> = 0.007).